Similar Articles
1401 A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma
1402 Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
1403 First multicenter study for risk factors for hepatocellular carcinoma development in North Africa
1404 Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals
1405 Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient
1406 Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations
1407 Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
1408 Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor
1409 Leptin in hepatocellular carcinoma
1410 Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA